{"id":875,"date":"2025-11-07T13:47:33","date_gmt":"2025-11-07T18:47:33","guid":{"rendered":"https:\/\/stutteringresearch.org\/?post_type=research&#038;p=875"},"modified":"2025-11-17T09:11:07","modified_gmt":"2025-11-17T14:11:07","slug":"orfeo-estudio-descubrimiento-investigacion","status":"publish","type":"research","link":"https:\/\/stutteringresearch.org\/es\/research\/orpheus-study-breakthrough-research\/","title":{"rendered":"Estudio Orfeo \u2013 Gemlapodect en el Tratamiento de Adultos con Trastorno de Fluidez de Inicio Infantil (Tartamudez)"},"content":{"rendered":"<h2 dir=\"ltr\">Investigaci\u00f3n revolucionaria<\/h2>\n<div class=\"ms-outlook-mobile-reference-message skipProofing\" dir=\"ltr\">\n<p>En la reuni\u00f3n de la Cumbre del SNCC celebrada esta semana en Boston, se publicaron los resultados del estudio Orpheus en una presentaci\u00f3n en p\u00f3ster con el fundador de STARS, <span class=\"outlook-search-highlight\" data-markjs=\"true\">Gerald<\/span> A. Maguire MD, como autor principal. El estudio, patrocinado por Noema Pharma (noemapharma.com), investig\u00f3 el gemlapodect en el tratamiento de adultos con Trastorno del Desarrollo de la Fluidez de Inicio Infantil (Tartamudez). El gemlapodect es un medicamento en investigaci\u00f3n que act\u00faa como un inhibidor de PDE 10A, el cual puede modular la hiperactividad de la se\u00f1alizaci\u00f3n de dopamina en las regiones estriatales del cerebro que se postula subyacen a la tartamudez. El estudio involucr\u00f3 un dise\u00f1o novedoso de aleatorizaci\u00f3n con respuesta al placebo y utiliz\u00f3 una escala de calificaci\u00f3n reci\u00e9n desarrollada (la MLGSSS) para evaluar la gravedad de la tartamudez. Al eliminar a los sujetos que mostraron una respuesta inicial al placebo, el gemlapodect mostr\u00f3 un efecto de tratamiento significativo en comparaci\u00f3n con el placebo. El gemlapodect fue generalmente bien tolerado, con efectos secundarios (reportados como leves a moderados) de sedaci\u00f3n, acatisia (inquietud) y diston\u00eda (rigidez muscular) mayores que con el placebo. A diferencia de los medicamentos bloqueadores de dopamina previamente estudiados en la tartamudez, no se observ\u00f3 aumento de peso.<\/p>\n<p>Aunque gemlapodect sigue en fase de investigaci\u00f3n y se necesita m\u00e1s estudio, este trabajo marca un paso prometedor en el tratamiento de la tartamudez.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Investigaci\u00f3n revolucionaria<\/p>\n<p>En la reuni\u00f3n cumbre de la CNS celebrada esta semana en Boston, se presentaron los resultados del estudio Orpheus en un p\u00f3ster con el Dr. Gerald A Maguire, fundador de STARS, como autor principal. El estudio, patrocinado por Noema Pharma (noemapharma.com), investig\u00f3 el gemlapodect en el tratamiento de adultos con Trastorno de la Fluidez de Comienzo Infantil (Tartamudez).<\/p>","protected":false},"featured_media":0,"template":"","class_list":["post-875","research","type-research","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Orpheus Study - Gemlapodect in the Treatment of Adults with Childhood Onset Fluency Disorder (Stuttering) - STARS - Stuttering Treatment and Research Society<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stutteringresearch.org\/es\/investigacion\/orfeo-estudio-descubrimiento-investigacion\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Orpheus Study - Gemlapodect in the Treatment of Adults with Childhood Onset Fluency Disorder (Stuttering) - STARS - Stuttering Treatment and Research Society\" \/>\n<meta property=\"og:description\" content=\"Breakthrough Research  At the CNS Summit meeting held in Boston this week, the results of the Orpheus study were released in a poster presentation with STARS founder, Gerald A Maguire MD, as the lead author. \u00a0The study, sponsored by Noema Pharma (noemapharma.com) investigated \u00a0gemlapodect in the treatment of adults with Childhood Onset Fluency Disorder (Stuttering.)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stutteringresearch.org\/es\/investigacion\/orfeo-estudio-descubrimiento-investigacion\/\" \/>\n<meta property=\"og:site_name\" content=\"STARS - Stuttering Treatment and Research Society\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61574155787572\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-17T14:11:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stutteringresearch.org\/wp-content\/uploads\/2025\/05\/yoast-default.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stutteringresearch.org\\\/research\\\/orpheus-study-breakthrough-research\\\/\",\"url\":\"https:\\\/\\\/stutteringresearch.org\\\/research\\\/orpheus-study-breakthrough-research\\\/\",\"name\":\"Orpheus Study - Gemlapodect in the Treatment of Adults with Childhood Onset Fluency Disorder (Stuttering) - STARS - Stuttering Treatment and Research Society\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stutteringresearch.org\\\/#website\"},\"datePublished\":\"2025-11-07T18:47:33+00:00\",\"dateModified\":\"2025-11-17T14:11:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stutteringresearch.org\\\/research\\\/orpheus-study-breakthrough-research\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stutteringresearch.org\\\/research\\\/orpheus-study-breakthrough-research\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stutteringresearch.org\\\/research\\\/orpheus-study-breakthrough-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stutteringresearch.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research\",\"item\":\"https:\\\/\\\/stutteringresearch.org\\\/research\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Orpheus Study &#8211; Gemlapodect in the Treatment of Adults with Childhood Onset Fluency Disorder (Stuttering)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stutteringresearch.org\\\/#website\",\"url\":\"https:\\\/\\\/stutteringresearch.org\\\/\",\"name\":\"STARS - Stuttering Treatment and Research Society\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/stutteringresearch.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stutteringresearch.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stutteringresearch.org\\\/#organization\",\"name\":\"STARS - Stuttering Treatment and Research Society\",\"alternateName\":\"STARS\",\"url\":\"https:\\\/\\\/stutteringresearch.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/stutteringresearch.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stutteringresearch.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/yoast-org-logo.png\",\"contentUrl\":\"https:\\\/\\\/stutteringresearch.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/yoast-org-logo.png\",\"width\":700,\"height\":700,\"caption\":\"STARS - Stuttering Treatment and Research Society\"},\"image\":{\"@id\":\"https:\\\/\\\/stutteringresearch.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61574155787572\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Orpheus Study - Gemlapodect in the Treatment of Adults with Childhood Onset Fluency Disorder (Stuttering) - STARS - Stuttering Treatment and Research Society","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stutteringresearch.org\/es\/investigacion\/orfeo-estudio-descubrimiento-investigacion\/","og_locale":"es_MX","og_type":"article","og_title":"Orpheus Study - Gemlapodect in the Treatment of Adults with Childhood Onset Fluency Disorder (Stuttering) - STARS - Stuttering Treatment and Research Society","og_description":"Breakthrough Research  At the CNS Summit meeting held in Boston this week, the results of the Orpheus study were released in a poster presentation with STARS founder, Gerald A Maguire MD, as the lead author. \u00a0The study, sponsored by Noema Pharma (noemapharma.com) investigated \u00a0gemlapodect in the treatment of adults with Childhood Onset Fluency Disorder (Stuttering.)","og_url":"https:\/\/stutteringresearch.org\/es\/investigacion\/orfeo-estudio-descubrimiento-investigacion\/","og_site_name":"STARS - Stuttering Treatment and Research Society","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61574155787572","article_modified_time":"2025-11-17T14:11:07+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/stutteringresearch.org\/wp-content\/uploads\/2025\/05\/yoast-default.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/stutteringresearch.org\/research\/orpheus-study-breakthrough-research\/","url":"https:\/\/stutteringresearch.org\/research\/orpheus-study-breakthrough-research\/","name":"Orpheus Study - Gemlapodect in the Treatment of Adults with Childhood Onset Fluency Disorder (Stuttering) - STARS - Stuttering Treatment and Research Society","isPartOf":{"@id":"https:\/\/stutteringresearch.org\/#website"},"datePublished":"2025-11-07T18:47:33+00:00","dateModified":"2025-11-17T14:11:07+00:00","breadcrumb":{"@id":"https:\/\/stutteringresearch.org\/research\/orpheus-study-breakthrough-research\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stutteringresearch.org\/research\/orpheus-study-breakthrough-research\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/stutteringresearch.org\/research\/orpheus-study-breakthrough-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stutteringresearch.org\/"},{"@type":"ListItem","position":2,"name":"Research","item":"https:\/\/stutteringresearch.org\/research\/"},{"@type":"ListItem","position":3,"name":"Orpheus Study &#8211; Gemlapodect in the Treatment of Adults with Childhood Onset Fluency Disorder (Stuttering)"}]},{"@type":"WebSite","@id":"https:\/\/stutteringresearch.org\/#website","url":"https:\/\/stutteringresearch.org\/","name":"STARS - Sociedad de Investigaci\u00f3n y Tratamiento de la Tartamudez","description":"","publisher":{"@id":"https:\/\/stutteringresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stutteringresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/stutteringresearch.org\/#organization","name":"STARS - Sociedad de Investigaci\u00f3n y Tratamiento de la Tartamudez","alternateName":"STARS","url":"https:\/\/stutteringresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/stutteringresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/stutteringresearch.org\/wp-content\/uploads\/2025\/05\/yoast-org-logo.png","contentUrl":"https:\/\/stutteringresearch.org\/wp-content\/uploads\/2025\/05\/yoast-org-logo.png","width":700,"height":700,"caption":"STARS - Stuttering Treatment and Research Society"},"image":{"@id":"https:\/\/stutteringresearch.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61574155787572"]}]}},"_links":{"self":[{"href":"https:\/\/stutteringresearch.org\/es\/wp-json\/wp\/v2\/research\/875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stutteringresearch.org\/es\/wp-json\/wp\/v2\/research"}],"about":[{"href":"https:\/\/stutteringresearch.org\/es\/wp-json\/wp\/v2\/types\/research"}],"version-history":[{"count":9,"href":"https:\/\/stutteringresearch.org\/es\/wp-json\/wp\/v2\/research\/875\/revisions"}],"predecessor-version":[{"id":929,"href":"https:\/\/stutteringresearch.org\/es\/wp-json\/wp\/v2\/research\/875\/revisions\/929"}],"wp:attachment":[{"href":"https:\/\/stutteringresearch.org\/es\/wp-json\/wp\/v2\/media?parent=875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}